# Safety and Immunogenicity of RH5.1/Matrix-M in Adults and Infants Living in Tanzania

> **NCT04318002** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 60 (actual)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **BIOLOGICAL:** RH5.1/Matrix-M

## Key facts

- **NCT ID:** NCT04318002
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-21
- **Primary completion:** 2023-08-27
- **Final completion:** 2023-08-27
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-11-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04318002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04318002, "Safety and Immunogenicity of RH5.1/Matrix-M in Adults and Infants Living in Tanzania". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04318002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*